Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Scientific Reports|August 30, 2019
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast CancerStephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim, et al.ACS Pharmacology & Translational Science|January 15, 2026
Toll-Like Receptor 7/8 Antagonist Promotes Interleukin-10-Mediated Anti-inflammatory TherapyGrahmm A Funk, Jin Xie, Tamara A Kucaba, et al.Molecular Pharmaceutics|January 9, 2019
Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based NanovaccineHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.Scientific Reports|February 9, 2021
Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)Vidhi Khanna, Hyunjoon Kim, Wenqiu Zhang, et al.International Journal of Pharmaceutics|June 25, 2025
Immunostimulatory Pickering emulsion for oral vaccine deliveryJin Xie, Xiaodi Li, Grahmm A Funk, et al.Cellular Signalling|October 22, 2008
Multiple isoforms of beta-TrCP display differential activities in the regulation of Wnt signalingEunjeong Seo, Hyunjoon Kim, Rokki Kim, et al.Molecular Pharmaceutics|December 5, 2025
Route of Administration Determines the Immunosuppressive Mechanism of Bifunctional Peptide Inhibitors in a Mouse EAE ModelAndrea L Villela-Nava, Su Jeong Song, Jin Xie, et al.International Journal of Stem Cells|August 12, 2024
Applications of Single-Cell Omics Technologies for Induced Pluripotent Stem Cell-Based Cardiovascular ResearchHyunjoon Kim, Sohee Choi, HyoJung Heo, et al.Molecular Pharmaceutics|May 9, 2020
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer ImmunotherapyHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.Nucleic Acids Research|December 17, 2020
FAX-RIC enables robust profiling of dynamic RNP complex formation in multicellular organisms in vivoYongwoo Na, Hyunjoon Kim, Yeon Choi, et al.Pageof 6